论文信息 - A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial - 字舞流文

A New Reversible and Potent P2Y12 Receptor Antagonist (ACT-246475): Tolerability, Pharmacokinetics, and Pharmacodynamics in a First-in-Man Trial

J. Dingemanse | A. Krause | D. Baldoni | P. Guéret | S. Bruderer | M. Gutierrez | B. Astruc